Abstract:Endometriosis is a heterogeneous, recalcitrant disease that affects 10% of reproductive-age women. Resistance to conventional therapy critically raises the need for novel treatment options that target specific, dysregulated underlying molecular mechanisms. Dopamine receptor 2 (DRD2) has been shown to be associated with vascularity and fibrosis in endometriosis. Transcription factor KLF11 has been implicated in the pathogenesis of several human endocrine and reproductive tract diseases including endometriosis. KLF11 recruits epigenetic cofactors for regulation of target genes; dysregulation of critical target genes and associated signaling pathways results in diverse disease phenotypes. KLF11 regulates the expression of DRD2 in neurons. We investigated the regulation of DRD2 by KLF11 in the established eutopic and ectopic endometrial cell lines as well as in an animal model of endometriosis. KLF11 binding and activation of the DRD2 promoter was conserved across species. Promoter activation was reflected in correspondingly increased gene expression in an endometrial cell line and in primary endometriotic cells. In vivo, disease relevance was further evaluated in a surgically induced murine endometriotic model using Klf11-/- and wild-type mice. Consistent with loss of Klf11-mediated activation, lesions in Klf11-/- animals were associated with progressive fibrosis and decreased Drd2 expression. KLF11 binds specific epigenetic corepressors to repress several target genes. Activation of DRD2 by KLF11 could not be explained simply by loss of corepressor binding and is thus likely due to selective coactivator recruitment; identification of the precise pathway is the focus of ongoing investigation. Characterization of pharmacologically reversible epigenetic regulatory mechanisms has translational relevance in health and disease.

Dysregulation of Krüppel-like Factor 12 in the Development of Endometrial Cancer.

Krüppel-like Factor 12 Negatively Regulates Human Endometrial Stromal Cell Decidualization

Krüppel-like factor 12 decreases progestin sensitivity in endometrial cancer by inhibiting the progesterone receptor signaling pathway

KLF12 Promotes the Proliferation of Breast Cancer Cells by Reducing the Transcription of P21 in a P53-Dependent and P53-Independent Manner

CTHRC1 Overexpression Promotes Ectopic Endometrial Stromal Cell Proliferation, Migration and Invasion Via Activation of the Wnt/β-catenin Pathway

Variants of KLF5 and KLF12 were related to endometrial cancer risk in the Chinese population

KLF12 Interacts with TRIM27 to affect Cisplatin Resistance and Cancer Metastasis in Esophageal Squamous Cell Carcinoma by regulating L1CAM Expression

Krüppel-like factor 12 is a novel negative regulator of forkhead box O1 expression: a potential role in impaired decidualization

KLF12 Transcriptionally Regulates PD‐L1 Expression in Non‐small Cell Lung Cancer

The Krüppel-like Factor 9 ( KLF 9 ) Network in HEC-1-A Endometrial Carcinoma Cells Suggests the Carcinogenic Potential of Dys-Regulated KLF 9 Expression

Increased Krüppel-like Factor 12 in Recurrent Implantation Failure Impairs Endometrial Decidualization by Repressing Nur77 Expression

Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT

Decreased expression of KLF6 in ectopic endometrial stromal cells contributes to endometriosis progression by targeting CTNNB1

Elevated levels of KLF12 impair trophoblast syncytialization via GCM1 downregulation

Identification of KLF17 as a novel epithelial to mesenchymal transition inducer via direct activation of TWIST1 in endometrioid endometrial cancer.

KCTD12 Regulates Colorectal Cancer Cell Stemness Through the ERK Pathway

The Clinical Relevance and Function of Krüppel-Like Factor 16 in Breast Cancer.

RING Domain of Zinc Finger Protein Like 1 is Essential for Cell Proliferation in Endometrial Cancer Cell Line RL95-2.

KLF11 is an Epigenetic Mediator of DRD2/Dopaminergic Signaling in Endometriosis

Expression and Clinical Significance of KLK5-8 in Endometrial Cancer

Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.